APO Research

APO RESEARCH · REPORT

Glucoamylase

Glucoamylase is a glycoprotein with the molecular weight 60000-100000 containing mannose, glucose, galactose and alduronic acid. It can be used to the non-reduced end of amylum and dextrin molecule to produce glucose. Glucoamylase is widely used biocatalysts in food industry. The major application of glucoamylase is the catalysis of alcohol, starch sugar, beer, white spirit and other fermentation industries.

Product & engineering

Understand the product.

Glucoamylase is a glycoprotein with the molecular weight 60000-100000 containing mannose, glucose, galactose and alduronic acid. It can be used to the non-reduced end of amylum and dextrin molecule to produce glucose. Glucoamylase is widely used biocatalysts in food industry. The major application of glucoamylase is the catalysis of alcohol, starch sugar, beer, white spirit and other fermentation industries.

Selected research

Market Outlook & Growth Opportunities

Global Glucoamylase Market Outlook and Growth Opportunities 2026

Market perspective

Glucoamylase is a glycoprotein with the molecular weight 60000-100000 containing mannose, glucose, galactose and alduronic acid. It can be used to the non-reduced end of amylum and dextrin molecule to produce glucose. Glucoamylase is widely used biocatalysts in food industry. The major application of glucoamylase is the catalysis of alcohol, starch sugar, beer, white spirit and other fermentation industries.

Global Glucoamylase key players include Novozymes, Genencor, Amano Enzyme, DSM, AB Enzymes, etc. Global top five players hold a share about 65%.

China is the largest market, with a share about 30%, followed by Europe and North America, having a total share about 45 percent.

Read the full market overview

In terms of product, Liquid Glucoamylase is the largest segment, with a share about 95%. And in terms of application, the largest application is Alcohol, followed by Starch Sugar, Beer, White Spirit, etc.

This report provides an overview of the global Glucoamylase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucoamylase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucoamylase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucoamylase market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucoamylase Segment by Company

Novozymes

Genencor

Amano Enzyme

DSM

AB Enzymes

BASF

Shandong Longda

VTR

SunHY

YSSH

BSDZYME

Challenge Group

Jinyuan

Sunson

Glucoamylase Segment by Type

Liquid Glucoamylase

Solid Glucoamylase

Glucoamylase Segment by Application

Alcohol

Starch Sugar

Beer

White Spirit

Other

Glucoamylase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glucoamylase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glucoamylase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glucoamylase significant trends, drivers, influence factors in global and regions.

6. To analyze Glucoamylase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucoamylase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucoamylase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucoamylase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucoamylase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucoamylase industry.

Chapter 3: Detailed analysis of Glucoamylase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glucoamylase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glucoamylase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glucoamylase Industry Trends Table 2. Glucoamylase Industry Drivers Table 3. Glucoamylase Industry Opportunities and Challenges Table 4. Glucoamylase Industry Restraints Table 5. Global Glucoamylase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glucoamylase Revenue Share by Company (2021-2026) Table 7. Global Glucoamylase Sales Volume by Company (K MT) & (2021-2026) Table 8. Global Glucoamylase Sales Volume Share by Company (2021-2026) Table 9. Global Glucoamylase Average Price (USD/MT) of Company (2021-2026) Table 10. Global Glucoamylase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glucoamylase Key Company Manufacturing Base & Headquarters Table 12. Global Glucoamylase Company, Product Type & Application Table 13. Global Glucoamylase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucoamylase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Liquid Glucoamylase Table 18. Significant Companies of Solid Glucoamylase Table 19. Global Glucoamylase Sales Volume by Type 2021 VS 2025 VS 2032 (K MT) Table 20. Global Glucoamylase Sales Volume by Type (2021-2026) & (K MT) Table 21. Global Glucoamylase Sales Volume by Type (2027-2032) & (K MT) Table 22. Global Glucoamylase Sales Volume Share by Type (2021-2026) Table 23. Global Glucoamylase Sales Volume Share by Type (2027-2032) Table 24. Global Glucoamylase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Glucoamylase Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Glucoamylase Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Glucoamylase Sales Value Share by Type (2021-2026) Table 28. Global Glucoamylase Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Alcohol Table 30. Significant Companies of Starch Sugar Table 31. Significant Companies of Beer Table 32. Significant Companies of White Spirit Table 33. Significant Companies of Other Table 34. Global Glucoamylase Sales Volume by Application 2021 VS 2025 VS 2032 (K MT) Table 35. Global Glucoamylase Sales Volume by Application (2021-2026) & (K MT) Table 36. Global Glucoamylase Sales Volume by Application (2027-2032) & (K MT) Table 37. Global Glucoamylase Sales Volume Share by Application (2021-2026) Table 38. Global Glucoamylase Sales Volume Share by Application (2027-2032) Table 39. Global Glucoamylase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Glucoamylase Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Glucoamylase Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Glucoamylase Sales Value Share by Application (2021-2026) Table 43. Global Glucoamylase Sales Value Share by Application (2027-2032) Table 44. Global Glucoamylase Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 45. Global Glucoamylase Sales by Region (2021-2026) & (K MT) Table 46. Global Glucoamylase Sales Market Share by Region (2021-2026) Table 47. Global Glucoamylase Sales by Region (2027-2032) & (K MT) Table 48. Global Glucoamylase Sales Market Share by Region (2027-2032) Table 49. Global Glucoamylase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Glucoamylase Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Glucoamylase Sales Value Share by Region (2021-2026) Table 52. Global Glucoamylase Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Glucoamylase Sales Value Share by Region (2027-2032) Table 54. Global Glucoamylase Market Average Price (USD/MT) by Region (2021-2026) Table 55. Global Glucoamylase Market Average Price (USD/MT) by Region (2027-2032) Table 56. Global Glucoamylase Sales by Country: 2021 VS 2025 VS 2032 (K MT) Table 57. Global Glucoamylase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Glucoamylase Sales by Country (2021-2026) & (K MT) Table 59. Global Glucoamylase Sales Market Share by Country (2021-2026) Table 60. Global Glucoamylase Sales by Country (2027-2032) & (K MT) Table 61. Global Glucoamylase Sales Market Share by Country (2027-2032) Table 62. Global Glucoamylase Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Glucoamylase Sales Value Market Share by Country (2021-2026) Table 64. Global Glucoamylase Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Glucoamylase Sales Value Market Share by Country (2027-2032) Table 66. Novozymes Company Information Table 67. Novozymes Business Overview Table 68. Novozymes Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 69. Novozymes Glucoamylase Product Portfolio Table 70. Novozymes Recent Development Table 71. Genencor Company Information Table 72. Genencor Business Overview Table 73. Genencor Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. Genencor Glucoamylase Product Portfolio Table 75. Genencor Recent Development Table 76. Amano Enzyme Company Information Table 77. Amano Enzyme Business Overview Table 78. Amano Enzyme Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Amano Enzyme Glucoamylase Product Portfolio Table 80. Amano Enzyme Recent Development Table 81. DSM Company Information Table 82. DSM Business Overview Table 83. DSM Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. DSM Glucoamylase Product Portfolio Table 85. DSM Recent Development Table 86. AB Enzymes Company Information Table 87. AB Enzymes Business Overview Table 88. AB Enzymes Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. AB Enzymes Glucoamylase Product Portfolio Table 90. AB Enzymes Recent Development Table 91. BASF Company Information Table 92. BASF Business Overview Table 93. BASF Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. BASF Glucoamylase Product Portfolio Table 95. BASF Recent Development Table 96. Shandong Longda Company Information Table 97. Shandong Longda Business Overview Table 98. Shandong Longda Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 99. Shandong Longda Glucoamylase Product Portfolio Table 100. Shandong Longda Recent Development Table 101. VTR Company Information Table 102. VTR Business Overview Table 103. VTR Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 104. VTR Glucoamylase Product Portfolio Table 105. VTR Recent Development Table 106. SunHY Company Information Table 107. SunHY Business Overview Table 108. SunHY Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 109. SunHY Glucoamylase Product Portfolio Table 110. SunHY Recent Development Table 111. YSSH Company Information Table 112. YSSH Business Overview Table 113. YSSH Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 114. YSSH Glucoamylase Product Portfolio Table 115. YSSH Recent Development Table 116. BSDZYME Company Information Table 117. BSDZYME Business Overview Table 118. BSDZYME Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 119. BSDZYME Glucoamylase Product Portfolio Table 120. BSDZYME Recent Development Table 121. Challenge Group Company Information Table 122. Challenge Group Business Overview Table 123. Challenge Group Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 124. Challenge Group Glucoamylase Product Portfolio Table 125. Challenge Group Recent Development Table 126. Jinyuan Company Information Table 127. Jinyuan Business Overview Table 128. Jinyuan Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 129. Jinyuan Glucoamylase Product Portfolio Table 130. Jinyuan Recent Development Table 131. Sunson Company Information Table 132. Sunson Business Overview Table 133. Sunson Glucoamylase Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 134. Sunson Glucoamylase Product Portfolio Table 135. Sunson Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Glucoamylase Distributors List Table 139. Glucoamylase Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Glucoamylase Product Image Figure 2. Global Glucoamylase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucoamylase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glucoamylase Sales (2021-2032) & (K MT) Figure 5. Global Glucoamylase Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Glucoamylase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Liquid Glucoamylase Image Figure 10. Solid Glucoamylase Image Figure 11. Global Glucoamylase Sales Volume by Type (2021 VS 2025 VS 2032) & (K MT) Figure 12. Global Glucoamylase Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Glucoamylase Sales Volume Share by Type (2021-2032) Figure 14. Global Glucoamylase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Glucoamylase Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Glucoamylase Sales Value Share by Type (2021-2032) Figure 17. Alcohol Image Figure 18. Starch Sugar Image Figure 19. Beer Image Figure 20. White Spirit Image Figure 21. Other Image Figure 22. Global Glucoamylase Sales Volume by Application (2021 VS 2025 VS 2032) & (K MT) Figure 23. Global Glucoamylase Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Glucoamylase Sales Volume Share by Application (2021-2032) Figure 25. Global Glucoamylase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Glucoamylase Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Glucoamylase Sales Value Share by Application (2021-2032) Figure 28. Global Glucoamylase Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 29. Global Glucoamylase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Glucoamylase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Glucoamylase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Glucoamylase Sales Value (2021-2032) & (US$ Million) Figure 33. North America Glucoamylase Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Glucoamylase Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Glucoamylase Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Glucoamylase Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Glucoamylase Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Glucoamylase Sales Value (2021-2032) & (US$ Million) Figure 39. South America Glucoamylase Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Glucoamylase Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Glucoamylase Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Glucoamylase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Glucoamylase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Glucoamylase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Glucoamylase Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Glucoamylase Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Glucoamylase
  • Solid Glucoamylase
Applications
  • Alcohol
  • Starch Sugar
  • Beer
  • White Spirit
  • Other
Companies covered
  • Novozymes
  • Genencor
  • Amano Enzyme
  • DSM
  • AB Enzymes
  • BASF
  • Shandong Longda
  • VTR
  • SunHY
  • YSSH
  • BSDZYME
  • Challenge Group
  • Jinyuan
  • Sunson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucoamylase Sales Value (2021-2032)
  4. 1.2.2 Global Glucoamylase Sales Volume (2021-2032)
  5. 1.2.3 Global Glucoamylase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glucoamylase Market Dynamics
  1. 2.1 Glucoamylase Industry Trends
  2. 2.2 Glucoamylase Industry Drivers
  3. 2.3 Glucoamylase Industry Opportunities and Challenges
  4. 2.4 Glucoamylase Industry Restraints
3 Glucoamylase Market by Company
  1. 3.1 Global Glucoamylase Company Revenue Ranking in 2025
  2. 3.2 Global Glucoamylase Revenue by Company (2021-2026)
  3. 3.3 Global Glucoamylase Sales Volume by Company (2021-2026)
  4. 3.4 Global Glucoamylase Average Price by Company (2021-2026)
  5. 3.5 Global Glucoamylase Company Ranking (2024-2026)
  6. 3.6 Global Glucoamylase Company Manufacturing Base and Headquarters
  7. 3.7 Global Glucoamylase Company Product Type and Application
  8. 3.8 Global Glucoamylase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glucoamylase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glucoamylase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glucoamylase Market by Type
  1. 4.1 Glucoamylase Type Introduction
  2. 4.1.1 Liquid Glucoamylase
  3. 4.1.2 Solid Glucoamylase
  4. 4.2 Global Glucoamylase Sales Volume by Type
  5. 4.2.1 Global Glucoamylase Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glucoamylase Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Glucoamylase Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Glucoamylase Sales Value by Type
  9. 4.3.1 Global Glucoamylase Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glucoamylase Sales Value by Type (2021-2032)
  11. 4.3.3 Global Glucoamylase Sales Value Share by Type (2021-2032)
5 Glucoamylase Market by Application
  1. 5.1 Glucoamylase Application Introduction
  2. 5.1.1 Alcohol
  3. 5.1.2 Starch Sugar
  4. 5.1.3 Beer
  5. 5.1.4 White Spirit
  6. 5.1.5 Other
  7. 5.2 Global Glucoamylase Sales Volume by Application
  8. 5.2.1 Global Glucoamylase Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glucoamylase Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Glucoamylase Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Glucoamylase Sales Value by Application
  12. 5.3.1 Global Glucoamylase Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glucoamylase Sales Value by Application (2021-2032)
  14. 5.3.3 Global Glucoamylase Sales Value Share by Application (2021-2032)
6 Glucoamylase Regional Sales and Value Analysis
  1. 6.1 Global Glucoamylase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucoamylase Sales by Region (2021-2032)
  3. 6.2.1 Global Glucoamylase Sales by Region: 2021-2026
  4. 6.2.2 Global Glucoamylase Sales by Region (2027-2032)
  5. 6.3 Global Glucoamylase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glucoamylase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glucoamylase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glucoamylase Sales Value by Region (2027-2032)
  9. 6.5 Global Glucoamylase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glucoamylase Sales Value (2021-2032)
  12. 6.6.2 North America Glucoamylase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glucoamylase Sales Value (2021-2032)
  15. 6.7.2 Europe Glucoamylase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glucoamylase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glucoamylase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glucoamylase Sales Value (2021-2032)
  21. 6.9.2 South America Glucoamylase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glucoamylase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glucoamylase Sales Value Share by Country, 2025 VS 2032
7 Glucoamylase Country-level Sales and Value Analysis
  1. 7.1 Global Glucoamylase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glucoamylase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glucoamylase Sales by Country (2021-2032)
  4. 7.3.1 Global Glucoamylase Sales by Country (2021-2026)
  5. 7.3.2 Global Glucoamylase Sales by Country (2027-2032)
  6. 7.4 Global Glucoamylase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glucoamylase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glucoamylase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glucoamylase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glucoamylase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glucoamylase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glucoamylase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glucoamylase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glucoamylase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glucoamylase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glucoamylase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glucoamylase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glucoamylase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glucoamylase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glucoamylase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glucoamylase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glucoamylase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glucoamylase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glucoamylase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glucoamylase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glucoamylase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glucoamylase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glucoamylase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glucoamylase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glucoamylase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glucoamylase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glucoamylase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glucoamylase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glucoamylase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glucoamylase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glucoamylase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glucoamylase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glucoamylase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glucoamylase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glucoamylase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glucoamylase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glucoamylase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glucoamylase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glucoamylase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glucoamylase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glucoamylase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glucoamylase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glucoamylase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glucoamylase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glucoamylase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glucoamylase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glucoamylase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glucoamylase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glucoamylase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glucoamylase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glucoamylase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glucoamylase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glucoamylase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glucoamylase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glucoamylase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glucoamylase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glucoamylase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glucoamylase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glucoamylase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glucoamylase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glucoamylase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glucoamylase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glucoamylase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glucoamylase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glucoamylase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glucoamylase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glucoamylase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glucoamylase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glucoamylase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glucoamylase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glucoamylase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glucoamylase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glucoamylase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glucoamylase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glucoamylase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glucoamylase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glucoamylase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glucoamylase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glucoamylase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glucoamylase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glucoamylase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glucoamylase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glucoamylase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glucoamylase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glucoamylase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glucoamylase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glucoamylase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novozymes
  2. 8.1.1 Novozymes Company Information
  3. 8.1.2 Novozymes Business Overview
  4. 8.1.3 Novozymes Glucoamylase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novozymes Glucoamylase Product Portfolio
  6. 8.1.5 Novozymes Recent Developments
  7. 8.2 Genencor
  8. 8.2.1 Genencor Company Information
  9. 8.2.2 Genencor Business Overview
  10. 8.2.3 Genencor Glucoamylase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Genencor Glucoamylase Product Portfolio
  12. 8.2.5 Genencor Recent Developments
  13. 8.3 Amano Enzyme
  14. 8.3.1 Amano Enzyme Company Information
  15. 8.3.2 Amano Enzyme Business Overview
  16. 8.3.3 Amano Enzyme Glucoamylase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amano Enzyme Glucoamylase Product Portfolio
  18. 8.3.5 Amano Enzyme Recent Developments
  19. 8.4 DSM
  20. 8.4.1 DSM Company Information
  21. 8.4.2 DSM Business Overview
  22. 8.4.3 DSM Glucoamylase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 DSM Glucoamylase Product Portfolio
  24. 8.4.5 DSM Recent Developments
  25. 8.5 AB Enzymes
  26. 8.5.1 AB Enzymes Company Information
  27. 8.5.2 AB Enzymes Business Overview
  28. 8.5.3 AB Enzymes Glucoamylase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AB Enzymes Glucoamylase Product Portfolio
  30. 8.5.5 AB Enzymes Recent Developments
  31. 8.6 BASF
  32. 8.6.1 BASF Company Information
  33. 8.6.2 BASF Business Overview
  34. 8.6.3 BASF Glucoamylase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BASF Glucoamylase Product Portfolio
  36. 8.6.5 BASF Recent Developments
  37. 8.7 Shandong Longda
  38. 8.7.1 Shandong Longda Company Information
  39. 8.7.2 Shandong Longda Business Overview
  40. 8.7.3 Shandong Longda Glucoamylase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Longda Glucoamylase Product Portfolio
  42. 8.7.5 Shandong Longda Recent Developments
  43. 8.8 VTR
  44. 8.8.1 VTR Company Information
  45. 8.8.2 VTR Business Overview
  46. 8.8.3 VTR Glucoamylase Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 VTR Glucoamylase Product Portfolio
  48. 8.8.5 VTR Recent Developments
  49. 8.9 SunHY
  50. 8.9.1 SunHY Company Information
  51. 8.9.2 SunHY Business Overview
  52. 8.9.3 SunHY Glucoamylase Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 SunHY Glucoamylase Product Portfolio
  54. 8.9.5 SunHY Recent Developments
  55. 8.10 YSSH
  56. 8.10.1 YSSH Company Information
  57. 8.10.2 YSSH Business Overview
  58. 8.10.3 YSSH Glucoamylase Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 YSSH Glucoamylase Product Portfolio
  60. 8.10.5 YSSH Recent Developments
  61. 8.11 BSDZYME
  62. 8.11.1 BSDZYME Company Information
  63. 8.11.2 BSDZYME Business Overview
  64. 8.11.3 BSDZYME Glucoamylase Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 BSDZYME Glucoamylase Product Portfolio
  66. 8.11.5 BSDZYME Recent Developments
  67. 8.12 Challenge Group
  68. 8.12.1 Challenge Group Company Information
  69. 8.12.2 Challenge Group Business Overview
  70. 8.12.3 Challenge Group Glucoamylase Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Challenge Group Glucoamylase Product Portfolio
  72. 8.12.5 Challenge Group Recent Developments
  73. 8.13 Jinyuan
  74. 8.13.1 Jinyuan Company Information
  75. 8.13.2 Jinyuan Business Overview
  76. 8.13.3 Jinyuan Glucoamylase Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jinyuan Glucoamylase Product Portfolio
  78. 8.13.5 Jinyuan Recent Developments
  79. 8.14 Sunson
  80. 8.14.1 Sunson Company Information
  81. 8.14.2 Sunson Business Overview
  82. 8.14.3 Sunson Glucoamylase Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sunson Glucoamylase Product Portfolio
  84. 8.14.5 Sunson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucoamylase Value Chain Analysis
  2. 9.1.1 Glucoamylase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucoamylase Sales Mode & Process
  6. 9.2 Glucoamylase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucoamylase Distributors
  9. 9.2.3 Glucoamylase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research